By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Catalyst Biosciences, Inc. 

260 Littlefield Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-871-0761 Fax: n/a



Company News
Bay Area's Catalyst Biosciences to Merge With Unlucky Targacept (TRGT) 3/6/2015 6:36:53 AM
Catalyst Biosciences, Inc. and ISU ABXIS CO., LTD Announce Collaboration to Develop Next-Generation Best-In-Class Factor IX Therapeutics 10/9/2013 9:50:09 AM
Pfizer Inc. (PFE) Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences, Inc. 1/5/2012 10:56:23 AM
Catalyst Biosciences, Inc. Receives $4 Million Milestone Payment from Pfizer Inc. (PFE) for Progress in Lead Hemostasis Program 12/16/2010 6:42:47 AM
Catalyst Biosciences, Inc. Appoints William J. Dawson Chief Financial Officer 3/2/2010 11:42:17 AM
Catalyst Biosciences, Inc. Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics; Catalyst Will Receive Milestone up to $195 Million 7/7/2009 7:20:08 AM
Wyeth (WYE), Catalyst Biosciences, Inc. Sign Deal Worth Potentially $500 Million 6/30/2009 7:03:35 AM
Catalyst Biosciences, Inc. Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development 3/24/2009 12:12:44 PM
Catalyst Biosciences, Inc. Raises $40 Million in Series C Financing 12/3/2008 6:42:53 AM
Catalyst Biosciences, Inc. Appoints Dr. Todd Lorenz Chief Medical Officer 10/28/2008 8:14:08 AM